Trial Profile
Multiple dose-ascending trial of oral AFN 1252 in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2015
Price :
$35
*
At a glance
- Drugs Debio 1452 (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- 02 Oct 2015 Results published in the Journal of Chemotherapy
- 04 May 2011 New trial record
- 02 May 2011 Results have been reported in an Affinium Pharmaceuticals media release.